文献速递心脑血管急症重症综合管理与镇静镇痛

急性心肌梗死合并心脏骤停住院患者姑息治疗使用的时间趋势、预测因素与结局

Temporal Trends, Predictors and Outcomes of Inpatient Palliative Care Use in Cardiac Arrest Complicating Acute Myocardial Infarction.
PubMed 文献 · Resuscitation · 2021-11-12
一句话结论2000-2017年美国AMI-CA住院患者中姑息治疗使用从<1%升至11.5%,使用姑息治疗者住院死亡率更高(84.6% vs 42.9%,校正OR 3.62),作者认为仍显著未充分利用。

基于美国全国住院患者样本(2000-2017)的584,263例急性心肌梗死合并心脏骤停(AMI-CA)成人住院患者分析显示,仅26,919例(4.6%)接受住院姑息治疗服务,使用率从2000年的<1%升至2017年的11.5%。接受姑息治疗者年龄更大、合并症更多、心源性休克和急性非心脏器官衰竭比例更高,冠脉造影(48.6% vs 63.3%)、经皮冠状动脉介入治疗(37.4% vs 46.9%)和冠状动脉旁路移植术比例更低(均p<0.001)。多因素logistic回归显示姑息治疗组住院死亡率更高(84.6% vs 42.9%,校正OR 3.62[95%CI 3.48-3.76]),倾向匹配分析一致(84.7% vs 66.2%,p<0.001);姑息治疗组更常签署不复苏医嘱(47.6% vs 3.7%)、住院时间更短(4天 vs 5天)、更常出院至专业护理机构(73.6% vs 20.4%,均p<0.001)。作者认为尽管使用率增加,姑息治疗在AMI-CA中仍显著未充分利用,提示需进一步整合姑息治疗专家参与AMI-CA照护。

要点

  • 2000-2017年584,263例AMI-CA住院患者中仅26,919例(4.6%)接受住院姑息治疗,使用率从<1%升至11.5%。
  • 接受姑息治疗者年龄更大、合并症更多、心源性休克和急性非心脏器官衰竭比例更高,冠脉造影(48.6% vs 63.3%)、PCI(37.4% vs 46.9%)和CABG比例更低(均p<0.001)。
  • 姑息治疗组住院死亡率更高:多因素校正OR 3.62(95%CI 3.48-3.76),倾向匹配分析84.7% vs 66.2%(p<0.001)。
  • 姑息治疗组不复苏医嘱更常见(47.6% vs 3.7%),住院时间更短(4天 vs 5天),出院至专业护理机构更多(73.6% vs 20.4%),均p<0.001。
  • 年龄更大、合并症负担更重和急性非心脏器官衰竭是姑息治疗使用的预测因素。

适用人群与场景

  • 成人急性心肌梗死合并心脏骤停(AMI-CA)住院患者,数据来自美国全国住院患者样本(2000-2017)。

研究设计与关键结果

  • 研究类型:基于美国全国住院患者样本(2000-2017)的分析;样本量584,263例AMI-CA住院患者;接受住院姑息治疗者26,919例(4.6%)。
  • 姑息治疗使用率从2000年的<1%上升至2017年的11.5%。
  • 接受姑息治疗者年龄更大、合并症更多、心源性休克和急性器官衰竭比例更高;冠脉造影(48.6% vs 63.3%)、经皮冠状动脉介入治疗(37.4% vs 46.9%)和冠状动脉旁路移植术比例更低(均p<0.001)。
  • 年龄更大、合并症负担更重和急性非心脏器官衰竭是姑息治疗使用的预测因素。
  • 住院死亡率:姑息治疗组84.6% vs 未使用组42.9%,多因素logistic回归校正OR 3.62(95%CI 3.48-3.76);倾向匹配分析84.7% vs 66.2%(p<0.001)。
  • 姑息治疗组不复苏医嘱更常见(47.6% vs 3.7%),住院时间更短(4天 vs 5天),出院至专业护理机构更常见(73.6% vs 20.4%),均p<0.001;倾向匹配分析结果一致。

证据类型、等级与局限

  • 证据类型:基于全国住院患者样本的观察性研究;使用多因素logistic回归和倾向匹配校正混杂。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,尽管AMI-CA中姑息治疗使用增加,但仍显著未充分利用,提示需进一步整合姑息治疗专家参与AMI-CA照护。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Utilization of inpatient palliative care services (PCS) has been infrequently studied in patients with cardiac arrest complicating acute myocardial infarction (AMI-CA).

METHODS: Adult AMI-CA admissions were identified from the National Inpatient Sample (2000-2017). Outcomes of interest included temporal trends and predictors of PCS use and in-hospital mortality, length of stay, hospitalization costs and discharge disposition in AMI-CA admissions with and without PCS use. Multivariable logistic regression and propensity matching were used to adjust for confounding.

RESULTS: Among 584,263 AMI-CA admissions, 26,919 (4.6%) received inpatient PCS. From 2000 to 2017 PCS use increased from <1% to 11.5%. AMI-CA admissions that received PCS were on average older, had greater comorbidity, higher rates of cardiogenic shock, acute organ failure, lower rates of coronary angiography (48.6% vs 63.3%), percutaneous coronary intervention (37.4% vs 46.9%), and coronary artery bypass grafting (all p < 0.001). Older age, greater comorbidity burden and acute non-cardiac organ failure were predictive of PCS use. In-hospital mortality was significantly higher in the PCS cohort (multivariable logistic regression: 84.6% vs 42.9%, adjusted odds ratio 3.62 [95% CI 3.48-3.76]; propensity-matched analysis: 84.7% vs. 66.2%, p < 0.001). The PCS cohort received a do- not-resuscitate status more often (47.6% vs. 3.7%), had shorter hospital stays (4 vs 5 days), and were discharged more frequently to skilled nursing facilities (73.6% vs. 20.4%); all p < 0.001. These results were consistent in the propensity-matched analysis.

CONCLUSIONS: Despite an increase in PCS use in AMI-CA, it remains significantly underutilized highlighting the role for further integrating of these specialists in AMI-CA care.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Kanwar A, Patlolla SH, Singh M, et al. Temporal Trends, Predictors and Outcomes of Inpatient Palliative Care Use in Cardiac Arrest Complicating Acute Myocardial Infarction. Resuscitation. 2021. PMID: 34780813. doi:10.1016/j.resuscitation.2021.10.044

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。